Physician profile
Daniel G Dean
NPI 1114510062
$3,151.05
in general payments reported to CMS, 2019-2025
15 companies · $87.79 in 2025
The $87.79 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $418 · 2023: $934 · 2024: $1,454 · 2025: $87.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,685 · Travel and Lodging: $763 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,685.34 |
| Travel and Lodging | $763.35 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $742.78 | 2021-2024 | |
| Curonix LLC | $659.80 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $525.58 | 2023 | Synchromedii, N/A, Specify Surescan Mri 5-6-5 |
| Abbott Laboratories | $364.40 | 2023-2024 | Proclaim, Eterna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $258.80 | 2023-2025 | Relistor |
| Lilly USA, LLC | $141.76 | 2021-2023 | Reyvow, Emgality |
| Upsher-Smith Laboratories LLC | $117.77 | 2021-2022 | |
| Pfizer INC. | $73.11 | 2023-2025 | |
| Amgen INC. | $63.38 | 2022-2023 | Aimovig |
| Biodelivery Sciences International, INC. | $53.35 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $50.05 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.01 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $25.58 | 2024 | |
| Saluda Medical Americas, INC. | $24.49 | 2024 | Evoke |
| Collegium Pharmaceutical, INC. | $19.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.